Table.
HPV Vaccination | ||||||
---|---|---|---|---|---|---|
HepB Vaccinationb | Girlsc | Boysc | ||||
State | Rate | Rank (95% CI) | Rate | Rank (95% CI) | Rate | Rank (95% CI) |
All | 92.2 | NA | 57.4 | NA | 31.0 | NA |
Alabama | 93.2 | 23 (11-32) | 52.6 | 40 (27-48) | 21.2 | 49 (39-51) |
Alaska | 90.9 | 36 (28-42) | 54.8 | 31 (22-44) | 24.9 | 39 (30-46) |
Arizona | 84.5 | 50 (48-51) | 60.1 | 18 (9-29) | 33.0 | 17 (10-27) |
Arkansas | 90.1 | 41 (31-44) | 47.9 | 49 (40-50) | 22.7 | 43 (36-50) |
California | 90.5 | 39 (30-43) | 66.7 | 3 (2-12) | 40.5 | 5 (3-11) |
Colorado | 93.1 | 24 (11-33) | 58.7 | 25 (12-34) | 36.7 | 11 (5-19) |
Connecticut | 97.0 | 2 (1-6) | 61.7 | 13 (6-25) | 40.9 | 4 (3-10) |
Delaware | 94.9 | 9 (5-19) | 66.2 | 4 (2-13) | 38.4 | 7 (4-14) |
District of Columbia | 90.7 | 37 (24-44) | 64.0 | 10 (2-21) | 49.7 | 2 (2-2) |
Florida | 95.9 | 6 (2-11) | 51.8 | 42 (28-49) | 28.1 | 30 (20-41) |
Georgia | 97.1 | 1 (1-5) | 54.9 | 30 (21-45) | 32.0 | 19 (11-31) |
Hawaii | 92.3 | 30 (17-37) | 64.5 | 8 (2-18) | 42.4 | 3 (3-8) |
Idaho | 87.2 | 48 (42-50) | 53.8 | 35 (23-47) | 27.4 | 34 (22-42) |
Illinois | 93.6 | 21 (10-29) | 54.4 | 33 (25-43) | 30.7 | 24 (16-32) |
Indiana | 94.2 | 12 (7-27) | 51.7 | 43 (30-48) | 21.9 | 45 (38-50) |
Iowa | 93.7 | 20 (9-30) | 58.8 | 24 (11-33) | 27.4 | 35 (22-41) |
Kansas | 88.2 | 44 (39-49) | 41.8 | 51 (49-51) | 22.1 | 44 (37-50) |
Kentucky | 94.6 | 10 (6-23) | 50.9 | 45 (31-49) | 19.2 | 50 (44-51) |
Louisiana | 95.9 | 5 (2-10) | 59.7 | 19 (10-30) | 31.5 | 21 (13-32) |
Maine | 91.9 | 32 (21-39) | 62.1 | 12 (5-24) | 37.9 | 9 (4-15) |
Maryland | 93.0 | 26 (11-34) | 52.4 | 41 (27-48) | 33.9 | 15 (8-26) |
Massachusetts | 95.6 | 7 (2-13) | 67.0 | 2 (2-11) | 39.8 | 6 (3-11) |
Michigan | 94.3 | 11 (7-26) | 59.0 | 23 (11-33) | 27.9 | 32 (21-40) |
Minnesota | 94.0 | 13 (7-29) | 61.3 | 14 (6-27) | 28.0 | 31 (20-40) |
Mississippi | 93.7 | 19 (9-30) | 44.5 | 50 (47-51) | 21.2 | 48 (39-51) |
Missouri | 87.9 | 45 (40-49) | 50.8 | 46 (31-49) | 23.7 | 42 (33-49) |
Montana | 88.6 | 43 (38-48) | 53.2 | 38 (25-47) | 26.0 | 36 (26-45) |
Nebraska | 92.8 | 27 (13-35) | 63.7 | 11 (3-20) | 33.3 | 16 (10-27) |
Nevada | 91.2 | 35 (25-42) | 59.6 | 20 (10-31) | 27.6 | 33 (22-41) |
New Hampshire | 96.6 | 3 (1-7) | 66.1 | 5 (2-13) | 38.1 | 8 (4-14) |
New Jersey | 96.3 | 4 (1-9) | 54.5 | 32 (22-45) | 28.6 | 28 (19-39) |
New Mexico | 89.5 | 42 (35-46) | 60.4 | 16 (8-28) | 31.8 | 20 (12-31) |
New York | 93.9 | 14 (9-26) | 57.0 | 26 (18-35) | 34.4 | 14 (10-21) |
North Carolina | 93.0 | 25 (12-34) | 60.8 | 15 (7-27) | 30.9 | 22 (14-34) |
North Dakota | 92.4 | 29 (14-38) | 60.1 | 17 (8-30) | 32.3 | 18 (11-30) |
Ohio | 90.5 | 38 (29-43) | 55.7 | 29 (19-42) | 25.6 | 38 (28-45) |
Oklahoma | 93.8 | 18 (9-28) | 56.6 | 27 (16-40) | 35.0 | 13 (7-22) |
Oregon | 90.5 | 40 (30-43) | 65.6 | 6 (2-14) | 30.3 | 26 (16-35) |
Pennsylvania | 93.8 | 17 (9-28) | 59.5 | 21 (11-29) | 35.3 | 12 (8-20) |
Rhode Island | 95.3 | 8 (4-15) | 78.0 | 1 (1-1) | 59.3 | 1 (1-1) |
South Carolina | 93.5 | 22 (10-31) | 49.4 | 48 (35-50) | 21.8 | 46 (38-51) |
South Dakota | 91.4 | 34 (21-42) | 55.9 | 28 (17-43) | 23.9 | 41 (32-49) |
Tennessee | 93.9 | 16 (8-29) | 51.4 | 44 (30-49) | 25.9 | 37 (26-45) |
Texas | 87.6 | 46 (43-49) | 53.5 | 36 (28-45) | 29.6 | 27 (19-34) |
Utah | 86.6 | 49 (43-50) | 49.8 | 47 (34-50) | 19.0 | 51 (44-51) |
Vermont | 93.9 | 15 (8-29) | 64.3 | 9 (3-18) | 36.7 | 10 (5-18) |
Virginia | 91.4 | 33 (22-41) | 54.1 | 34 (21-47) | 24.4 | 40 (30-48) |
Washington | 87.3 | 47 (42-50) | 64.6 | 7 (2-18) | 30.8 | 23 (14-33) |
West Virginia | 84.3 | 51 (49-51) | 53.0 | 39 (26-47) | 28.3 | 29 (20-39) |
Wisconsin | 92.7 | 28 (13-36) | 59.4 | 22 (10-32) | 30.4 | 25 (15-35) |
Wyoming | 92.0 | 31 (19-39) | 53.4 | 37 (25-47) | 21.6 | 47 (39-51) |
Abbreviations: HepB, hepatitis B; HPV, human papillomavirus; NA, not applicable.
aCoverage estimates incorporate survey weights from National Immunization Survey-Teen.20 Ranks and their 95% CIs were calculated using a simulation analysis, which generated 100 000 sets of simultaneous ranks and examined the distribution of the ranks across iterations.
bProvider-verified receipt of 3 doses of HepB vaccine.
cProvider-verified receipt of at least 1 dose of HPV vaccine.